Fonadelpar

Names

[ Name ]:
Fonadelpar

[Synonym ]:
fonadelpar
FK5ZAD810Z
{[3-(2-{4-Isopropyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl}ethyl)-5-methyl-1,2-benzoxazol-6-yl]oxy}acetic acid
Acetic acid, 2-[[5-methyl-3-[2-[4-(1-methylethyl)-2-[4-(trifluoromethyl)phenyl]-5-thiazolyl]ethyl]-1,2-benzisoxazol-6-yl]oxy]-

Biological Activity

[Description]:

Fonadelpar is a PPARδ agonist, used in the research of neuroparalytic keratopathy.

[Related Catalog]:

Research Areas >> Neurological Disease

[Target]

PPARδ

[In Vitro]

Fonadelpar is a PPARδ agonist, used in the research of neuroparalytic keratopathy[1].

[References]

[1]. Kobayashi, et al. Therapeutic agent for neuroparalytic keratopathy containing benzisoxazol compound-based PPARδ agonist. WO2016199871A1.

[Related Small Molecules]

GW9662 | Retinoic acid | Elafibranor | GW501516 | Troglitazone | T0070907 | Pemafibrate | CDDO-Im | Wy-14643 | GW0742 | GW1929 | FH535 | Icariin | Daidzein | Fisetin

Chemical & Physical Properties

[ Density]:
1.3±0.1 g/cm3

[ Boiling Point ]:
607.6±65.0 °C at 760 mmHg

[ Molecular Formula ]:
C₂₅H₂₃F₃N₂O₄S

[ Molecular Weight ]:
504.521

[ Flash Point ]:
321.3±34.3 °C

[ Exact Mass ]:
504.133057

[ LogP ]:
7.02

[ Vapour Pressure ]:
0.0±1.8 mmHg at 25°C

[ Index of Refraction ]:
1.587

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.